Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for DataMeds AI, Inc (MEDS : NSDQ)

• Company Description    DataMeds AI Inc. is a health IT company which focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units to deliver a healthcare experience for consumers. The company incorporates the artificial intelligence platform EinsteinRx(TM) and blockchain-enabled smart contacts platform PharmacyChain(TM). DataMeds AI Inc., formerly known as Wellgistics Health, is based in TAMPA, Fla. Number of Employees: 7

• Price / Volume Information    Yesterday's Closing Price: $0.92 Daily Weekly Monthly 20 Day Moving Average: 700,343 shares Shares Outstanding: 3.20 (millions) Market Capitalization: $2.93 (millions) Beta: -1.77 52 Week High: $83.61 52 Week Low: $0.82 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -42.75% -42.49% 12 Week -75.51% -76.03% Year To Date -95.41% -95.93%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3000 BAYPORT DRIVE SUITE 950 - TAMPA,FL 33607 USA ph: 844-203-6092 fax: - ir@wellgisticshealth.com https://datamedsai.com

• General Corporate Information    Officers Prashant Patel - Chief Executive Officer Eric Sherb - Interim Chief Financial Officer Suren Ajjarapu - Director Prashant Patel - Director Gary Herman - Director Peer Information DataMeds AI, Inc (HLIS) DataMeds AI, Inc (AZTA) DataMeds AI, Inc (APYI) DataMeds AI, Inc (RNVA) DataMeds AI, Inc (HMSY) DataMeds AI, Inc (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 949503205 SIC: 5122 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/18/26 Share - Related Items Shares Outstanding: 3.20 Most Recent Split Date: 5.00 (0.02:1) Beta: -1.77 Market Capitalization: $2.93 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/18/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 0.37 EPS Growth vs. Year Ago Period: 40.73% vs. Previous Quarter: 6.86% Sales Growth vs. Year Ago Period: -77.15% vs. Previous Quarter: 14.10% ROE 06/30/26 - - 03/31/26 - - 12/31/25 - - ROA 06/30/26 - -171.81 03/31/26 - -145.69 12/31/25 - -175.38 Current Ratio 06/30/26 - 0.14 03/31/26 - 0.09 12/31/25 - 0.09 Quick Ratio 06/30/26 - 0.10 03/31/26 - 0.03 12/31/25 - 0.04 Operating Margin 06/30/26 - -782.23 03/31/26 - -434.93 12/31/25 - -367.35 Net Margin 06/30/26 - -1,100.16 03/31/26 - -545.69 12/31/25 - -433.95 Pre-Tax Margin 06/30/26 - -1,100.17 03/31/26 - -545.69 12/31/25 - -433.95 Book Value 06/30/26 - -6.85 03/31/26 - -5.95 12/31/25 - -6.94 Inventory Turnover 06/30/26 - 4.95 03/31/26 - 4.22 12/31/25 - 4.27 Debt-to-Equity 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Capital 06/30/26 - - 03/31/26 - - 12/31/25 - -

Powered by Zacks Investment Research ©